Page last updated: 2024-08-01 12:40:25

24-hydroxyvitamin d3

Description

24-hydroxyvitamin D3: RN given refers to (3beta,5Z,7E,24R)-isomer [MeSH]

Cross-References

ID SourceID
PubMed CID5283729
MeSH IDM0096943

Synonyms (8)

Synonym
24-hydroxyvitamin d3
(24r)-24-hydroxyvitamin d3 / (24r)-24-hydroxycholecalciferol
(5z,7e)-(3s,24r)-9,10-seco-5,7,10(19)-cholestatriene-3,24-diol
LMST03020244
56720-87-7
9,10-secocholesta-5,7,10(19)-triene-3,24-diol, (3beta,5z,7e,24r)-
24(r)-hydroxyvitamin d3
24(r)-hydroxycholecalciferol

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (37.50)18.7374
1990's2 (25.00)18.2507
2000's1 (12.50)29.6817
2010's1 (12.50)24.3611
2020's1 (12.50)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
cycloheximideantibiotic fungicide;
cyclic ketone;
dicarboximide;
piperidine antibiotic;
piperidones;
secondary alcohol
anticoronaviral agent;
bacterial metabolite;
ferroptosis inhibitor;
neuroprotective agent;
protein synthesis inhibitor
1985198539.0low010000
d-alpha tocopherolalpha-tocopherolalgal metabolite;
antiatherogenic agent;
anticoagulant;
antioxidant;
antiviral agent;
EC 2.7.11.13 (protein kinase C) inhibitor;
immunomodulator;
micronutrient;
nutraceutical;
plant metabolite
202320231.0low000001
dactinomycinactinomycinmutagen1985198539.0low010000
calcitriolD3 vitamins;
hydroxycalciol;
triol
antineoplastic agent;
antipsoriatic;
bone density conservation agent;
calcium channel agonist;
calcium channel modulator;
hormone;
human metabolite;
immunomodulator;
metabolite;
mouse metabolite;
nutraceutical
1985200629.3medium011100
cholecalciferolD3 vitamins;
hydroxy seco-steroid;
seco-cholestane;
secondary alcohol;
steroid hormone
geroprotector;
human metabolite
1981198143.0low010000
24,25-dihydroxyvitamin d 31981201529.7high032110
zk159222vitamin D2006200618.0medium000100
guanosine 5'-o-(3-thiotriphosphate)nucleoside triphosphate analogue1993199331.0low001000
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Acute Myelogenous Leukemia01987198737.0low010000
Body Weight01993199331.0low001000
Cancer of Pituitary01993199331.0low001000
Chronic Hepatitis C0201520159.0low000010
Cirrhosis, Liver0201520159.0low000010
Hepatitis C, Chronic0201520159.0low000010
Hyperparathyroidism01993199331.0low001000
Leukemia, Myeloid, Acute01987198737.0low010000
Liver Cirrhosis0201520159.0low000010
Neuroblastoma0202320231.0low000001
Pituitary Neoplasms01993199331.0low001000
Pregnancy01985198539.0low010000

Pharmacokinetics (1)

ArticleYear
Human pharmacokinetics of orally administered (24 R)-hydroxycalcidiol.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies, , Volume: 31, Issue:7
1993

Bioavailability (1)

ArticleYear
Human pharmacokinetics of orally administered (24 R)-hydroxycalcidiol.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies, , Volume: 31, Issue:7
1993